AP NEWS

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Alnylam Pharmaceuticals, Inc. Investors (ALNY)

September 27, 2018

BENSALEM, Pa.--(BUSINESS WIRE)--Sep 27, 2018--Law Offices of Howard G. Smith announces an investigation on behalf of Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY ) investors concerning the Company and its officers’ possible violations of federal securities laws.

The investigation concerns whether the Company overstated the efficacy and safety of Alnylam’s lipid complex injection ONPATTRO. And, the Company’s shares fell following news that a FDA review document highlighted specific risks associated with ONPATTRO following the cardiac deaths in patients treated with ONPATTRO.

If you purchased Alnylam securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to  howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005822/en/

CONTACT: Law Offices of Howard G. Smith

Howard G. Smith, Esquire

215-638-4847

888-638-4847

howardsmith@howardsmithlaw.com

www.howardsmithlaw.com

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: Law Offices of Howard G. Smith

Copyright Business Wire 2018.

PUB: 09/27/2018 02:44 PM/DISC: 09/27/2018 02:44 PM

http://www.businesswire.com/news/home/20180927005822/en

AP RADIO
Update hourly